FDA Inspectional Observations on Hygiene, Cleaning and Sanitation
Register now for ECA's GMP Newsletter
A detailed analysis of the annually published FDA Inspectional Observation Summaries (483s) shows that the topics of hygiene, cleaning and disinfecting are still frequent reasons of deviations. More than 120 entries in the FY 2010 Inspectional Observation Summaries prove that there is a high potential of improvement and optimizing.
Following a short extract of the 483s overview:
| Ref No | Frequency | Short description |
| 21 CFR 211.67(a) | 61 | Cleaning / Sanitizing / Maintenance |
| 21 CFR 211.67(c) | 29 | Cleaning/maintenance records not kept |
| 21 CFR 211.56(b) | 13 | Written sanitation procedures lacking |
| 21 CFR 211.56(a) | 12 | Sanitation--buildings not clean, free of infestation |
| 21 CFR 211.28(a) | 4 | Clothing appropriate for duties performed |
| 21 CFR 211.42(c)(10)(v) | 4 | Cleaning System |
| 21 CFR 211.28(b) | 3 | Habits of good sanitation & health |
| 21 CFR 211.182 | 12 | Personnel checking the cleaning are not dating/signing equipment log |
These results are collected from the summaries part "drugs". Additionally there are hygienic deviations in the parts "Biologicals and "Devices". Especially noticeable is the high number of observations regarding written SOPs or the deficient realisation of their content. Written hygienic plans, including the standard operating procedures and the training of the personnel in their realisation have been required by relevant national Medicines Acts and the international GMP guidelines for a long time, but it appears that the implementation is still a big challenge for the industry. Maybe we can see here too a relation to the insufficient training of the personnel which was critizised by the FDA too (see our news FDA criticises SOP Training in pharmaceutical Companies).
Please see the FY 2010 Inspectional Observational Summaries for further details.
In this regard, please pay attention to ECA's Education Course "Contamination Control" in Budapest, Hungary, from 21-23 March 2012. This course will cover all relevant aspects of hygiene in a pharmaceutical manufacturing site.
Author
Axel H. Schroeder
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
07.05.2025Microbiology - EDQM asks for Comments on the new or revised Chapters
01.04.2025Update of the GMP Guideline for Sterile Medicinal Products in China
01.04.2025USP publishes Draft Chapter on Contamination Control Strategy
06.03.2025EMA Q&A - When is Testing for Endotoxin Masking Effects necessary for biological Products?
26.02.2025Revision of USP chapter <1071> on rapid methods and its effect on other USP chapters
29.01.2025ANVISA - Alternative pyrogen test in the Brazilian pharmacopoeia